Retraction: Identification of novel SCN5A single nucleotide variants in Brugada syndrome: a territory-wide study from Hong Kong
2024

Retraction of Study on SCN5A Variants in Brugada Syndrome

Retraction

Author Information

Author(s): Frontiers Editorial Office

Conclusion

The study was retracted due to lack of appropriate ethical approval.

Supporting Evidence

  • The study did not receive appropriate ethical approval.
  • The retraction was approved by the Chief Editors for Frontiers in Physiology.

Takeaway

The study about a heart condition was taken back because it didn't follow the rules for getting permission to do the research.

Potential Biases

The study's findings are compromised due to ethical concerns.

Limitations

The study lacked appropriate ethical approval.

Digital Object Identifier (DOI)

10.3389/fphys.2024.1532081

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication